Axisresearch
- Healthcare
- Mordor Intelligence
- 116 pages
- Published: 13-06-2019
Market Overview
The 3D cell culture market is witnessing a stable growth due to the factors, like huge investments by life science companies for R&D, development of automated large-scale cell culture systems, and rising need for organ transplantation. Lack of experienced and skilled professionals and budget restriction for small and medium-sized laboratories are factors constraining the growth of the 3D cell culture market. However, increasing focus on regenerative medicine and stem cell is acting as an opportunity in the future. The scaffold-based segment holds the largest market share in the global market. The use of hydrogels in the scaffold-based 3D cell culture is the key factor driving the scaffold-based segment, as they can be derived naturally from protein and ECM components (laminin, fibrin, hyaluronic acid, chitosan, etc.). These gels are also biocompatible.
Scope of the Report
This report analyzes and discusses the 3D cell culture market. The market has been segmented on the basis of technology, application, end user, and geography. Based on technology, the market has been segmented into extracellular matrices (scaffolds), bioreactors, gels, scaffold-free platforms, microchips, and other technologies. The market, based on application, has been divided into research, drug discovery, tissue engineering, clinical applications, stem cell biology, and other applications. Based on end user, the market has been segregated into research laboratories and institutes, biotechnology and pharmaceutical industries, hospitals and diagnostic centers, and others end users.
Key Market Trends
Drug Discovery Segment is Expected to Exhibit the Fastest Growth Rate Over the Forecast Period
Conventionally, drug discovery has been carried out using animal models. However, with the explosion of drug molecules synthesized/discovered in the past two decades, there has been a growth in high-throughput screening. Consequently, drug discovery has become a process that was time-resource intensive. Additionally, animal testing is subject to ethical controversies. Consequently, the demand for alternative methods for drug testing and drug discovery processes has gained momentum.
A specific application of 3D cell culture in drug discovery is organ-on-chips. These systems are being extensively employed by cancer therapeutic manufacturers for improving the benefit-risk balance by targeting precisely a particular cell type, a defined biomechanism, or a precise receptor. The current up-trend in cancer therapeutics’ research is likely to further spur the application of 3D cell cultures in drug discovery. Over the forecast period, much novel cancer therapeutics are expected to receive market approval, which is likely to, in turn, drive the growth of the 3D cell culture market.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the overall 3D cell culture market with the United States accounting as the major contributor to the market. The United States is focusing more on R&D and is currently spending a lot on it. This has resulted in increasing technological advancements in the country. Many American applicants feature among the main patent applicants for the 3D cell culture domain. American applicants tend to develop their technologies in the United States, as well as in Asia. In 2016, an international collaboration between the United States, the United Kingdom, and the Netherlands, cancer-research heavy-weights, aimed to grow 1,000 new cell lines for scientists to study. The project is also expected to use cutting-edge techniques to generate its models, which will include 3D cultures called organoids, and cells that have been reprogrammed to grow indefinitely in culture. ICTDCCS 2018, 20th International Conference on 3D Cell Culture Systems, was held in Boston (the United States) on April 23-24, 2018. These factors have augmented the US 3D cell culture market and it is expected to further increase in the future.
Competitive Landscape
The 3D cell culture market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as 3D Biomatrix, Reinnervate Ltd, 3D Biotek LLC, Becton, Dickinson and Company, and Sigma Aldrich Corporation, is in turn, increasing the overall competitive rivalry in the market. Product advancements and improvement in the 3D cell culture technology by the major players are increasing the competitive rivalry.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Huge R&D Investment by Life Science Companies
4.3.2 Development of Automated Large-scale Cell Culture Systems
4.3.3 Rising Need for Organ Transplantation
4.3.4 Use of 3D Cell Culture Models as Alternative Tools for In Vivo Testing
4.3.5 Increasing Focus on Regenerative Medicine
4.4 Market Restraints
4.4.1 Lack of Experienced and Skilled Professionals
4.4.2 Budget Restriction for Small- and Medium-sized Laboratories
4.4.3 Lack of Consistency in 3D Cell Culture Products
4.4.4 Stringent Process Controls for Advanced Handling Capabilities
4.5 Industry Attractiveness- Porter’s Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Extracellular Matrices (Scafffolds)
5.1.2 Bioreactors
5.1.3 Gels
5.1.4 Scaffold-free Platforms
5.1.5 Microchips
5.1.6 Other Technologies
5.2 By Application
5.2.1 Research
5.2.2 Drug Discovery
5.2.3 Tissue Engineering
5.2.4 Clinical Applications
5.2.5 Stem Cell Biology
5.2.6 Other Applications
5.3 By End User
5.3.1 Research Laboratories and Institutes
5.3.2 Biotechnology and Pharmaceutical Companies
5.3.3 Hospitals and Diagnostic Centers
5.3.4 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 UK
5.4.2.2 Germany
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3D Biotek LLC
6.1.2 Becton Dickinson and Company
6.1.3 Sigma Aldrich Corporation
6.1.4 Corning Incorporated
6.1.5 Thermo Fisher Scientific
6.1.6 Global Cell Solutions Inc.
6.1.7 Nanofiber Solutions Incorporation
6.1.8 Insphero AG
6.1.9 Lonza Group
6.1.10 Nano 3D Biosciences
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Technology
Extracellular Matrices (Scafffolds)
Bioreactors
Gels
Scaffold-free Platforms
Microchips
Other Technologies
By Application
Research
Drug Discovery
Tissue Engineering
Clinical Applications
Stem Cell Biology
Other Applications
By End User
Research Laboratories and Institutes
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Centers
Other End Users
Geography
North America
US
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America